Cargando…
Iron-Chelating Agent Can Maintain Bone Homeostasis Disrupted by Iron Overload by Upregulating Wnt/Beta-Catenin Signaling
BACKGROUND: The incidence of osteoporotic fractures is increasing. In this study, we explored the activities of Wnt/β-catenin signaling in bone tissues with iron accumulation. METHODS: We established rat bipedal walking models (RBWM), and a portion of our RBWM rats were intraperitoneally injected wi...
Autores principales: | Xu, Wei, Yu, Ronghua, Zhu, Xiaodong, Li, Zhikun, Jia, Jianjun, Li, Dachuan, Chen, Yu, Zhang, Xiangyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273370/ https://www.ncbi.nlm.nih.gov/pubmed/32596380 http://dx.doi.org/10.1155/2020/8256261 |
Ejemplares similares
-
Iron Chelators in Treatment of Iron Overload
por: Entezari, Sarina, et al.
Publicado: (2022) -
A Review on Iron Chelators in Treatment of Iron Overload Syndromes
por: Mobarra, Naser, et al.
Publicado: (2016) -
Controversies on the Consequences of Iron Overload and Chelation in MDS
por: Vinchi, Francesca, et al.
Publicado: (2020) -
Iron Chelation Therapy with Deferasirox in the Management of Iron Overload in Primary Myelofibrosis
por: Elli, Elena Maria, et al.
Publicado: (2014) -
Korean Guideline for Iron Chelation Therapy in Transfusion-Induced Iron Overload
por: Jang, Jun Ho, et al.
Publicado: (2013)